Novel insights into biomarkers of progression in Desmoid tumor

B Liu, Z Sun, R Zhou, D Shen, S Zhu, L Chen… - Frontiers in …, 2023 - frontiersin.org
Desmoid tumor (DT) is a rare neoplasm characterized by the proliferation of myofibroblastic
cells that infiltrates and invades adjacent tissues. Due to its locally aggressive and recurrent …

Sufentanil combined with parecoxib sodium inhibits proliferation and metastasis of HER2-positive breast cancer cells and regulates epithelial-mesenchymal transition

S Xu, X Li, W Li, N Ma, H Ma, J Cui, X You… - Clinical & Experimental …, 2023 - Springer
Background Sufentanil combined with parecoxib sodium is a commonly used postoperative
medication for cancer patients. However, the effects of this combination therapy on human …

[HTML][HTML] The Role of Cyclin d1 in Radiotherapy Resistance of Advance Stage Nasopharyngeal Carcinoma: A Systematic Review

AC Romdhoni, AS Rajanagara… - … Pacific Journal of …, 2024 - pmc.ncbi.nlm.nih.gov
Objective: One of the biggest therapy challenges for nasopharyngeal cancer (NPC) is still
radioresistance. The radioresistance in NPC is thought to be caused by cyclin D1 …

[HTML][HTML] Correlation of before and after invasive breast cancer neoadjuvant chemotherapy for NFkB, cyclin D1, and survivin expression

P Rustamadji, E Wiyarta, I Anggreani - Iranian Journal of Pathology, 2023 - ncbi.nlm.nih.gov
Methods: Biomarkers expression (low and high) was used to classify 30 samples. ER, PR,
HER2, Ki-67 status, tumor grade, age, and NC response were assessed. The amounts of …

Cyclin D1 and Chemotherapy Response

R Cahyanur, C Irawan - Indonesian …, 2021 - mail.indonesianjournalofcancer.or.id
Cyclin D1 is a protein that plays a role in the transition from the G1 to S phase of the cell
cycle. Cyclin D1 expression has been found to increase in various malignancies and, in …